MONTVALE, N.J., Sept. 13 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals
Corp. (Nasdaq: MEMY) today announced that Jim Sulat, President and Chief
Executive Officer, will provide a company update at the Maxim Group Growth
Conference on Thursday, September 20, 2007 at 12:00 p.m. (EDT). The conference
is being held at the Grand Hyatt Hotel in New York City.
Interested parties may access the live webcast of the presentation by
visiting the "Investors" section of Memory Pharmaceuticals' website at
http://www.memorypharma.com. Archived versions of the webcast will be
available at the same location for one week following the presentation.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on
developing innovative drugs for the treatment of debilitating CNS disorders
such as Alzheimer's disease, schizophrenia, depression and bipolar disorder.
For additional information, please visit our website at
http://www.memorypharma.com.
SOURCE Memory Pharmaceuticals Corp.
-0- 09/13/2007
/CONTACT: Jzaneen Lalani, General Counsel, +1-201-802-7249; or Laura
Perry, Stern Investor Relations, Inc., +1-212-362-1200, both for Memory
Pharmaceuticals Corp./
/Web site: http://www.memorypharma.com /
(MEMY)
CO: Memory Pharmaceuticals Corp.
ST: New Jersey
IN: MTC BIO HEA
SU: TDS BFA
RD-CL
-- NYTH030 --
3155 09/13/2007 08:00 EDT http://www.prnewswire.com
